Intrexon | Third Point Ventures - Third Point Ventures

Improving the Lives of Patients with Transformational Approaches in Gene and Cell Therapies.

CEO: Randal Kirk
Location: Germantown, MA
Milestones: May 2013 - Third Point Ventures initial investment, Aug 2013 - Intrexon IPO (NASDAQ: PGEN)

Intrexon is an innovative leader in synthetic biology with a unique proposition, proven leadership team, and potential to transform multiple industries, including the health, food, and energy markets.